Project Grant R35GM155228

Award Date 8/1/24
Completion Date 5/31/29
Dollars Obligated $1.3M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $427,571 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Colorado-Denver to conduct research on the regulation of genome access and chromatin landscape dynamics. The project aims to uncover the molecular determinants of cellular identity and memory during development and in response to stimuli. Key focus areas include investigating the Polycomb pathway's role in maintaining cell...
This $391,250 five-year Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to uncover the mechanistic basis for how chromatin modifications recruit and activate the gene silencing enzymes Polycomb Repressive Complex 1 (PRC1), Polycomb Repressive Complex 2 (PRC2), and DNA Methyltransferase 1 (DNMT1). The awardee, The Regents of the University of Colorado (CU), will utilize an...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to investigate the effects of polyamines on chromatin function and their impact on cell fate and chromatin homeostasis. The 5-year, $411,250 award to The Trustees of Columbia University in the City of New York will enable the principal investigator to explore how changes in intracellular and extracellular polyamines...
This Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) provides $229,840 to Brandeis University to investigate how heterochromatin, a specialized region of the genome, helps cells maintain epigenetic memory. The research aims to: (1) engineer synthetic H3K9me binding modules to test how compartmentalization influences epigenetic memory, (2) determine how compartmentalization buffers cells from stochastic noise, and (3) identify critical...
The National Institute of General Medical Sciences (NIGMS) awarded a $294,647 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Texas at Dallas (UTD). The grant will fund a 4-year project from September 1, 2024 to August 31, 2028 to develop a theoretical, computational, and experimental framework for modeling epigenetic regulatory networks in human cells. The key objectives are to rapidly assemble and stably integrate libraries of...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program provides $508,750.00 to St. Jude Children's Research Hospital Inc. over a period from June 5, 2025 to March 31, 2030. The funding supports research to uncover the epigenetic mechanisms that underlie stem cell fate decisions during embryogenesis. The project focuses on understanding how histone H3 lysine 27 (H3K27) modifiers, such as...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $418,749 to Yale University to conduct research on the spatial regulation of epigenetic memory. The project aims to investigate how dynamic chromatin organization regulates epigenetic memory during development, through a combination of highly multiplexed epigenetic state and chromatin imaging analysis in an organoid model, live...
The National Institute of General Medical Sciences (NIGMS) awarded a $568,113 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to The Research Foundation For The State University Of New York, doing business as Stony Brook University. The grant, effective from February 1, 2025 to January 31, 2030, supports research investigating variant chromatin structures that decorate the chromosomal landscape of eukaryotic cells. Specifically, the project aims to...
The National Institute of General Medical Sciences (NIGMS) awarded a $528,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Sloan-Kettering Institute for Cancer Research located in New York, NY. The purpose of this 4-year grant, with a period of performance from September 30, 2024 to July 31, 2028, is to develop novel approaches to map the folding and protein occupancy of entire chromosomes with single-nucleosome resolution and single-molecule precision. The...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $1,271,250.00 to Weill Medical College of Cornell University to investigate the spatiotemporal regulation of epigenetic silencing by macromolecular interactions.

The research aims to elucidate the mechanism by which a critical histone methylation mark, H3K27me3, is precisely regulated during cell development and differentiation. The project will employ a series of separation-of-function mutants to fully interrogate how the dynamic interactions between the Polycomb Repressive Complex 2 (PRC2) and its accessory proteins regulate the specificity of epigenetic silencing. Understanding this mechanism has the potential to identify novel therapeutic targets for manipulating gene expression through epigenetic mechanisms. The award period runs from August 1, 2024 to May 31, 2029.

Generated 7/15/25, 9:03 AM